ADAM9 Antikörper (AA 704-733)
Kurzübersicht für ADAM9 Antikörper (AA 704-733) (ABIN1805678)
Target
Alle ADAM9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 704-733
-
Spezifität
- This ADAM9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 704-733 amino acids from the C-terminal region of human ADAM9.
-
Aufreinigung
- Ammonium sulfate precipitation
-
-
-
-
Applikationshinweise
- Approved: Flo (1:10 - 1:50), IHC, IHC-P (1:50 - 1:100), WB (1:1000)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
-
Haltbarkeit
- 6 months
-
-
- ADAM9 (ADAM Metallopeptidase Domain 9 (ADAM9))
-
Andere Bezeichnung
- ADAM9
-
Hintergrund
-
Name/Gene ID: ADAM9
Subfamily: Metallopeptidase M12B
Family: Protease
Synonyms: ADAM9, ADAM 9, CORD9, ADAM metallopeptidase domain 9, MCMP, Meltrin-gamma, Cone rod dystrophy 9, KIAA0021, MDC9, Mltng, Myeloma cell metalloproteinase -
Gen-ID
- 8754
-
UniProt
- Q13443
-
Pathways
- Cellular Response to Molecule of Bacterial Origin, SARS-CoV-2 Protein Interaktom
Target
-